No headlines found.
HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement
Globe Newswire (Wed, 13-Nov 9:00 AM ET)
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit
Globe Newswire (Mon, 14-Oct 4:15 PM ET)
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
Heartsciences trades on the NASDAQ stock market under the symbol HSCS.
As of December 13, 2024, HSCS stock price declined to $3.77 with 24,462 million shares trading.
HSCS has a beta of 1.32, meaning it tends to be more sensitive to market movements. HSCS has a correlation of 0.02 to the broad based SPY ETF.
HSCS has a market cap of $3.44 million. This is considered a Sub-Micro Cap stock.
Last quarter Heartsciences reported $0 in Revenue and $.00 earnings per share. This fell short of revenue expectation by $-200,000 and exceeded earnings estimates by $3.00.
The top ETF exchange traded funds that HSCS belongs to (by Net Assets): VXF.
HSCS has underperformed the market in the last year with a return of -76.8%, while SPY returned +29.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in HSCS shares. However, HSCS has outperformed the market in the last 3 month and 2 week periods, returning +24.0% and +27.7%, while SPY returned +7.8% and +0.3%, respectively. This indicates HSCS has been having a stronger performance recently.
HSCS support price is $3.78 and resistance is $4.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HSCS shares will trade within this expected range on the day.